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Introduction. Smokers are likely asking their physicians about the safety of e-cigarettes and their potential role
as a cessation tool; however, the research literature on this communication is scant. A pilot study of physicians in
the United States was conducted to investigate physician–patient communication regarding e-cigarettes.
Methods. A total of 158 physicians were recruited from a direct marketing e-mail list and completed a short,
web-based survey between January and April 2014. The survey addressed demographics, physician specialty,
patient–provider e-cigarette communication, and attitudes towards tobacco harm reduction.Results. Nearly two-thirds (65%) of physicians reported being asked about e-cigarettes by their patients, and
almost a third (30%) reported that they have recommended e-cigarettes as a smoking cessation tool. Male
physicians were signiﬁcantly more likely to endorse a harm reduction approach.
Discussion. Physician communication about e-cigarettes may shape patients' perceptions about the products.
More research is needed to explore the type of information that physicians share with their patients regarding
e-cigarettes and harm reduction.© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The tobacco market has changed dramatically, with cigarette use
declining and the use of other tobacco products expanding (U.S.
Department of Health and Human Services [USDHHS], 2014). In partic-
ular, e-cigarette use has risen signiﬁcantly and is especially high among
adult smokers (King et al., 2014). The tobacco control community has
begun to shift messaging from a traditional “all tobacco is equally bad”
approach to one distinguishing a risk continuum, with some focus on
e-cigarettes (Hajek et al., 2014). This messaging shift has been directed
not only at consumers, but also at physicians who treat tobacco users. A
recent article in the New England Journal of Medicine stated that
although the long-term effects of e-cigarette use are not known, these
devices are “probably much safer than combustible tobacco products”
(Fiore et al., 2014). Likewise, the 50th anniversary issue of the Surgeon
General's Report suggested that less risky cigarette substitutes, such as
e-cigarettes, might contribute to the reduction of tobacco-caused dis-
ease (USDHHS, 2014). However, harm reduction and e-cigarettes in
particular are not without controversy (Warner, 2002). Some re-
searchers point to the lack of safety and efﬁcacy data for the product
and because nicotine is addictive,many health professionals remain op-
posed to its use (Grana et al., 2014; Schraufnagel et al., 2014).00, New Brunswick, NJ 08903,
o).
. This is an open access article underConsequently, the public receives mixed messages about e-cigarettes,
even among experts. Given the role physicians play as a trusted and
credible source of health information, smokers are likely asking their
physicians about these products (Smith, 2011). Although the research
literature on physician communication regarding e-cigarettes is scant,
it suggests that discussions are taking place in the clinical setting and
some physicians are even recommending e-cigarettes to their patients
as a smoking cessation aid (Kandra et al., 2014). Given the paucity of
data and the explosive growth of e-cigarettes, a pilot study was con-
ducted to investigate e-cigarette physician–patient communication.Methods
We targeted a quota sample of 150 physicians who treat adults and
released sample until the quotawasmet. The sampling framewas obtain-
ed from Jubilant Marketing Solutions, a ﬁrm that maintains e-mail lists of
US physicians for direct marketing. Between January and April 2014, par-
ticipants were e-mailed a link to a short web-based survey and received a
$10 Starbucks gift card for participation. Given the large number of
e-mails that were non-deliverable (e.g., the physician no longer works
for organization, the e-mail address does not exist), calculating an accu-
rate response rate was problematic. The survey addressed demographics,
including physician characteristics (e.g., specialty), whether patients
had asked about e-cigarettes, whether the physician recommended e-
cigarettes, and attitudes towards tobacco harm reduction. Data werethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Physician–patient communication and perceptions regarding e-cigarettes, United States, 2014 (n = 158).
Patients asked about e-cigarettes Recommended e-cigarettes Endorses harm reduction approach
n % Crude OR Adjusted OR % Crude OR Adjusted OR % Crude OR Adjusted OR
Time
Jan/Feb 73 51.4% 1.0 (ref) 1.0 (ref) 21.4% 1.0 (ref) 1.0 (ref) 26.4% 1.0 (ref) 1.0 (ref)
Mar/Apr 85 77.1% 3.2 (1.6–6.4) 3.0 (1.3–6.8) 34.9% 2.0 (0.9–4.1) 1.8 (0.8–4.1) 41.0% 1.9 (1.0–3.9) 1.4 (0.7–3.1)
Provider type
Primary care 62 50.8% 1.0 (ref) 1.0 (ref) 24.1% 1.0 (ref) 1.0 (ref) 23.3% 1.0 (ref) 1.0 (ref)
Specialist — tobacco diseasesa 96 74.0% 2.7 (1.4–5.5) 1.7 (0.8–3.8) 31.6% 1.5 (0.7–3.1) 1.1 (0.5–2.6) 41.1% 2.3 (1.1–4.8) 1.9 (0.8–4.1)
Sex
Female 44 62.8% 1.0 (ref) 1.0 (ref) 11.6% 1.0 (ref) 1.0 (ref) 18.2% 1.0 (ref) 1.0 (ref)
Male 112 65.8% 1.1 (0.5–2.4) 0.8 (0.3–1.9) 35.8% 4.2 (1.5–11.8) 3.5 (1.3–9.7) 40.9% 3.1 (1.3–7.4) 2.6 (1.0–6.6)
Asks/advises smokers to quit
Less than always 67 51.6% 1.0 (ref) 1.0 (ref) 25.4% 1.0 (ref) 1.0 (ref) 35.9% 1.0 (ref) 1.0 (ref)
Always 91 74.4% 2.7 (1.4–5.5) 2.7 (1.3–5.6) 30.3% 1.3 (0.6–2.7) 1.4 (0.6–3.1) 33.7% 0.9 (0.5–1.8) 0.9 (0.5–1.9)
Graduated med school
Before 1990 78 61.5% 1.0 (ref) 1.0 (ref) 27.3% 1.0 (ref) 1.0 (ref) 30.8% 1.0 (ref) 1.0 (ref)
1990–2010 73 68.1% 1.3 (0.7–2.6) 1.5 (0.7–3.1) 32.4% 1.3 (0.6–2.6) 1.5 (0.7–3.2) 40.8% 1.6 (0.8–3.1) 1.6 (0.8–3.2)
Overall 158 64.7% 29.7% 35.6%
Bold-faced values indicate statistical signiﬁcance at the p b 0.05 level.
a Includes oncologists, cardiologists, and pulmonologists.
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Results
Nearly 2 of 3 (65%) physicians reported being asked about
e-cigarettes by their patients, and almost a third (30%) reported
that they have recommended e-cigarettes (see Table 1). In addi-
tion, more than a third (36%) endorsed a harm-reduction approach
rather than a traditional “all tobacco is bad” position. Patient inqui-
ry about e-cigarettes signiﬁcantly increased over the course of the
study (March/April vs. January/February), and was higher among phy-
sicians who always assess smoking status. In addition, male physicians
were more likely to recommend e-cigarettes and endorse a harm-
reduction approach. Physicians who treat tobacco-caused disease
(e.g., oncologists, pulmonologists, cardiologists) generally had more e-
cigarette inquiries and a harm-reduction orientation, as were those who
graduated medical school after 1990, but these were not statistically
signiﬁcant.
Discussion
These ﬁndings demonstrate that many patients ask their physi-
cians about e-cigarettes, and despite a lack of scientiﬁc support,
many physicians recommend them. This is consistent with results
from a survey of North Carolina physicians in which nearly half
reported that patients ask about e-cigarettes sometimes or often
and a third recommended them to their patients for cessation
(Kandra et al., 2014). With a shift in perceptions from an “all tobacco
is bad” approach to a broader harm-reduction understanding, as en-
dorsed by 36% of physicians in our sample, the opportunity for phy-
sicians to consider smoking alternatives, such as e-cigarettes, has
emerged.
This study is subject to limitations. First, the direct email list did not
contain all physicians and was largely a sample of convenience, which
limits generalizability. Second, the quality of the list was problematic
(e.g., numerous emails were returned as “not deliverable”). While this
makes calculating a response rate difﬁcult, we estimated a minimum
response rate of 2.25%. Although low, this is comparable to other physi-
cian email surveys with higher quality samples. Indeed, Dykema et al.,
2011, using the American Medical Association Masterﬁle, conducted aphysician email survey and achieved a 2% response rate with 5 email
contacts (invite + 4 reminders) and no incentives; a $50 incentive
resulted in a slightly improved, but still low response rate of 7.4%
(2011).While physician email surveys are less than ideal for generalizable
data, they have an appropriate role to gather pilot data in a timely fashion.
This sample is valuable in that it establishes that patients are asking about
e-cigarettes and that responses to questions about the products are not
uniform among physicians.
Despite patients asking physicians about e-cigarettes, the scientiﬁc
community has limited data regarding physicians' perceptions about
these products or what type of information they share with their pa-
tients. This is concerning since physician–patient communication
about e-cigarettes may shape patients' perceptions (e.g., perceived
safety) or whether they decide to use e-cigarettes (e.g., switch from
cigarettes to e-cigarettes or stop using them because of a doctor's
warning). More strongly designed research studies are needed on this
timely and important issue.
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